Taysha Gene Therapies 대차 대조표 상태
재무 상태 기준 확인 5/6
Taysha Gene Therapies has a total shareholder equity of $108.9M and total debt of $37.8M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are $200.4M and $91.5M respectively.
주요 정보
34.8%
부채 비율
US$37.84m
부채
| 이자 보상 비율 | n/a |
| 현금 | US$172.74m |
| 주식 | US$108.87m |
| 총 부채 | US$91.53m |
| 총 자산 | US$200.39m |
최근 재무 상태 업데이트
Recent updates
Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data
Oct 14More Unpleasant Surprises Could Be In Store For Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) Shares After Tumbling 37%
Jun 27
Taysha Gene Therapies: Latest Rett Data Checks Momentum, Road Ahead Rocky
Jun 20Growth Investors: Industry Analysts Just Upgraded Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Revenue Forecasts By 23%
Apr 20What Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) 55% Share Price Gain Is Not Telling You
Mar 21Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts
Mar 20Taysha: Produces Solid Data But Has Abandoned Programs
Feb 06Taysha Gene Therapies Gets A 'Thumbs Up'
Mar 07재무 상태 분석
단기부채: TSHA's short term assets ($178.5M) exceed its short term liabilities ($34.2M).
장기 부채: TSHA's short term assets ($178.5M) exceed its long term liabilities ($57.3M).
부채 대 자본 내역 및 분석
부채 수준: TSHA has more cash than its total debt.
부채 감소: Insufficient data to determine if TSHA's debt to equity ratio has reduced over the past 5 years.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: TSHA has sufficient cash runway for more than a year based on its current free cash flow.
예측 현금 활주로: TSHA has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 7.1% each year.